Squarepoint’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
KGAMU
6CM
WPM
QOP
RC
Squarepoint's CDLX Position: Q3 2025 in Review
Squarepoint sold out of Cardlytics (CDLX) in Q3 2025, closing a stake of 8,912 shares — an estimated $147K sold.
Squarepoint first reported a position in CDLX in Q2 2019 and held it in 19 quarters. The position peaked at $3.42M in Q2 2021. 81 funds tracked by Wall St. Rank hold CDLX as of Q3 2025.
- Squarepoint reported no remaining Cardlytics position as of Q3 2025 after selling out during the quarter.
- Squarepoint sold 8,912 Cardlytics shares in Q3 2025, an estimated $147K.
- Squarepoint first reported a position in Cardlytics in Q2 2019 and held it in 19 quarters.
- Squarepoint's Cardlytics position peaked at $3.42M in Q2 2021.
- 81 funds tracked by Wall St. Rank held Cardlytics as of Q3 2025.
Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.